Quantifying the strength and durability of induced immunity to HIV infection in women engaging in unprotected sexual contacts with infected men

Mathematical and Computer Modelling

Volumn 36, Issue 11-13, 2002, Pages 1435-1458

  Kramer, I ^a   Shearer, G M ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS; Cellular immunity; HIV infection; Induced immunity; Innate immunity; Mucosal barriers; Seroprevalence

Indexed keywords

EID: 0037032849     PISSN: 08957177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7177(02)00299-6     Document Type: Article

References (26)

1. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels and S.J. O'Brien, Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene, Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE study (see comments) 273 (5283), 1856-1862 (1996); Erratum, Science 274 (5290), 1069 (1996).
2. S. Mazzoli, D. Trabattoni, S.L. Caputo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, M.L. Fusi, N. Tofani, M. Biasin, M.L. Villa, F. Mazzotta and M. Clerici, HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals, Nature Medicine 3 (11), 1250-1257 (1997).
3. S. Mazzoli, L. Lopalco, A. Salvi, D. Trabattoni, S.L. Caputo, F. Semplici, M. Biasin, C. Bi, A. Cosma, C. Pastori, F. Meacci, F. Mazzotta, M.L. Villa, A.G. Siccardi and M. Clerici, Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons, J. Infects. Dis. 180 (3), 871-875 (1999).
4. J.D. Wilson, G.S. Oggs, R.L. Allen, C. Davis, S. Shaunak, J. Downie, W. Dyer, C. Workman, S. Sullivan, A.J. McMichael and S.L. Rowland-Jones, Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection, AIDS 14 (3), 225-233 (2000).
5. V. Appay, D.F. Nixon, S.M. Donahoe, G.M. Gillespie, T. Dong, A. King, G.S. Ogg, H.M. Spiegel, C. Conlon, C.A. Spina, D.V. Havlir, D.D. Richman, A. Waters, P. Easterbrook, A.J. McMichael and S.L. Rowland-Jones, HIV-specific CD8(+) T cells produce antiviral cytokines but are impared in cytolytic function. J. Exp. Med. 192, 63-75 (2000)
6. A. Garzino-Demo, R.B. Moss, J.B. Margolick, F. Cleghorn, A. Sill, W.A. Blattner, F. Cocchi, D.J. Carlo, A.L. de Vico and R.C. Gallo, Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status, Proc. Natl. Acad. Sci. U.S.A. 96 (21), 11986-11991 (1999).
7. W. Chehadeh, S. Chabou, C. Frontier, G. Alm, G. Lion, L. Bochet, Y. Mout, P. Wattre and D. Hober, In HIV-1-infected patients, plasma levels of HIV-1 RNA are inversely correlated with IFN-alpha responsiveness of whole-blood cultures to sendai virus, J. Clin. Virol. 16 (2), 123-128 (2000).
8. E. Stylianou, P. Aukrust, K. Bendtzen, F. Muller and S.S. Froland, Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection, Clin. Exp. Immunol. 119 (3), 479-485 (2000).
9. D.W. Haas, J. Lavelle, J.P. Nadler, S.B. Greenberg, P. Frame, N. Mustafa, M. St. Clair, R. McKinnes, L. Dix, M. Elkins and J. Rooney, A randomized trial of interferon alpha therapy for HIV type 1 infection, AIDS Res. Hum. Retroviruses 16 (3), 183-190 (2000).
10. D. Zella, F. Romerio, S. Curreli, P. Secchiero, C. Cicala, D. Zagury and R.C. Gallo, INF-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells, J. Immunol. 164 (5), 2296-2302 (2000).
11. P. Bruhl, A. Kerschbaum, K. Zimmerman, M.M. Eibl and J.W. Mannhalter, Allostimulated lymphocytes inhibit replication of HIV type 1, AIDS Res. Hum. Retroviruses 12, 31 (1996).
12. L.A. Pinto, S. Sharpe, D.I. Cohen and G.M. Shearer, Alloantigen-stimulated anti HIV activity, Blood 92 (9), 3346-3354 (1998).
13. L.A. Pinto, V. Blazevic, B.K. Patterson, C. MacTrubey, M.J. Dolan and G.M. Shearer, Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation, J. Virol. 74 (10), 4505-4511 (2000).
14. K.R. Fowke, N.J. Nagelkerke, J. Kimani, J.N. Simonsen, A.O. Anzala, J.J. Bwayo, K.S. MacDonald, E.N. Ngugi and F.A. Plummer, Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya, Lancet 348 (9038), 1347-1351 (1996).
15. K.S. MacDonald, K. Fowke, J. Kimani, V.A. Dunand, N.J.D. Nagelkerke, T.B. Ball, E. Njagi, L.K. Gaur, R.C. Brunham, J. Wade, M.A. Luscher, P. Krausa, S. Rowland-Jones, E. Ngugi, J.J. Bwayo and F.A. Plummer, The influence of human leukocyte antigen supertypes on susceptibility and resistance to HIV-1 infection, J. Infect. Dis. 181, 1581-1589 (2000).
16. M.V. Ragni, L.A. Kingsley, P. Nimorwicz, P. Gupta and Ch.R. Rinaldo, HIV heterosexual transmission in hemophilia couples, lack of relation to T4 number, clinical diagnosis, or duration of HIV exposure, JAIDS 2 (6), 557-563 (1989).
17. A.M. Downs and I. de Vincenzi, Probability of heterosexual transmission of HIV: Relationship to the number of unprotected sexual acts, J. Acquir Immune Syndr. Hum. Retrovir. 11, 388-395 (1996).
18. T.A. Peterman, R.L. Stoneburner, J.R. Allen, H.W. Jaffe and J.W. Curran, Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections, JAMA 259, 55-58 (1988).
19. I.M. Belyakov, L.S. Wyatt, J.D. Ahlers, P. Earl, C.D. Pendelton, B.L. Kelsall, W. Strober, B. Moss and J.A. Berzofsky, Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein, J. Virol, 72 (10), 8264-8272 (1998).
20. I. de Vineenzi, For the European study group on heterosexual transmission of HIV. A longitudinal study of human immunodeficieney virus transmission by heterosexual partners, N. Engl. J. Med. 331, 341-346 (1994).
21. I. Kramer, J.A. Yorke and E.D. Yorke, Modelling nonmonogamous heterosexual transmission of AIDS, Mathl. Comput. Modelling 13 (1), 99-107 (1990).
22. E. Vittinghoff, J. Douglas, F. Judson, D. McKirnan, K. MacQueen and S. Buchbinder, Per-contact risk of human immunodeficiency virus transmission between male sex partners, Am. J. Epidemiol. 150, 306-311 (1999).
23. th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA (2000).
24. R. Kaul, S.L. Rowland-Jones, J. Kimani, T. Dong, H.-B. Yang, P. Klama, T. Rostron, E. Njagi, J.J. Bwayo, K.S. MacDonald, A.J. McMichael and F.A. Plummer, Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses, J. Clin. Invest. 107 (3), 341-349 (2001).
25. K. Fowke, Private communication.
26. R.H. Gray, R. Brookmeyer, M.J. Wawer, N.K. Sewankambo, T.C. Quinn, D. Serwadda and F. Wabwire-Mangen, The probability of HIV-1 transmission per coital act in monogamous HIV-discordant couples, Rakai, Uganda, Abstract M129e, Eighth Annual Retrovirus Conference, Chicago, IL (2001).